AU2007903316A0 - Transdermal delivery of active agents - Google Patents

Transdermal delivery of active agents

Info

Publication number
AU2007903316A0
AU2007903316A0 AU2007903316A AU2007903316A AU2007903316A0 AU 2007903316 A0 AU2007903316 A0 AU 2007903316A0 AU 2007903316 A AU2007903316 A AU 2007903316A AU 2007903316 A AU2007903316 A AU 2007903316A AU 2007903316 A0 AU2007903316 A0 AU 2007903316A0
Authority
AU
Australia
Prior art keywords
active agents
transdermal delivery
transdermal
delivery
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007903316A
Inventor
Stewart R. Himes
Michael R. Luke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apollo Life Science Ltd
Original Assignee
Apollo Life Science Ltd
Filing date
Publication date
Application filed by Apollo Life Science Ltd filed Critical Apollo Life Science Ltd
Publication of AU2007903316A0 publication Critical patent/AU2007903316A0/en
Priority to PCT/AU2008/000908 priority Critical patent/WO2008154705A1/en
Abandoned legal-status Critical Current

Links

AU2007903316A 2007-06-20 2007-06-20 Transdermal delivery of active agents Abandoned AU2007903316A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2008/000908 WO2008154705A1 (en) 2007-06-20 2008-06-20 Transdermal delivery of active agents

Publications (1)

Publication Number Publication Date
AU2007903316A0 true AU2007903316A0 (en) 2007-07-05

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20181346T1 (en) Transdermal pharmaceutical compositions comprising active agents
EP2389221A4 (en) Sustained released delivery of one or more agents
EP2960233B8 (en) New therapeutic agents
EP2012751A4 (en) Novel nanoparticles for delivery of active agents
WO2009023311A9 (en) Transcutaneous delivery of therapeutic agents
EP1909772A4 (en) Transdermal drug delivery formulation
HK1140139A1 (en) Multistage delivery of active agents
AU2009246332A8 (en) Micelles for intracellular delivery of therapeutic agents
GB0524958D0 (en) Transdermal administration of active agents
EP2291157A4 (en) Compositions and methods for the transdermal delivery of pharmaceutical compounds
IL210080A0 (en) Composition for transdermal delivery of cationic active agents
GB0524961D0 (en) Transdermal administration of active agents for systemic effect
EP2172238A4 (en) Drug solution injector
EP2365908A4 (en) Substrates providing multiple releases of active agents
EP2323605A4 (en) Transdermal delivery of oligosaccharides
EP2343964A4 (en) Transdermal delivery
EP2120896B8 (en) Medically active plaster
AU2007903316A0 (en) Transdermal delivery of active agents
EP2343963A4 (en) Transdermal delivery
GB0517838D0 (en) Transdermal active principle delivery means
AU2006905107A0 (en) Transdermal delivery of anti-inflammatory agents
AU2008902703A0 (en) Therapeutic agents
AU2007906363A0 (en) Nanostructures suitable for delivery of agents
AU2008903528A0 (en) Anti-malarial agents
AU2008903880A0 (en) Transdermal delivery system